Steven P Treon

Steven P Treon

UNVERIFIED PROFILE

Are you Steven P Treon?   Register this Author

Register author
Steven P Treon

Steven P Treon

Publications by authors named "Steven P Treon"

Are you Steven P Treon?   Register this Author

100Publications

2926Reads

24Profile Views

Cutaneous Eruptions from Ibrutinib Resembling EGFR Inhibitor-Induced Dermatologic Adverse Events.

J Am Acad Dermatol 2019 Dec 20. Epub 2019 Dec 20.

Center for Cutaneous Oncology, Department of Dermatology, Dana-Farber/Brigham & Women's Cancer Center, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2019.12.031DOI Listing
December 2019

How we manage Bing-Neel syndrome.

Br J Haematol 2019 Nov 20;187(3):277-285. Epub 2019 Aug 20.

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16167DOI Listing
November 2019

What is new in the treatment of Waldenstrom macroglobulinemia?

Leukemia 2019 Nov 7;33(11):2555-2562. Epub 2019 Oct 7.

Bing Center for Waldenstrom Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-019-0592-8DOI Listing
November 2019

CXCR4 mutations affect presentation and outcomes in patients with Waldenström macroglobulinemia: A systematic review.

Expert Rev Hematol 2019 Oct 30;12(10):873-881. Epub 2019 Jul 30.

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2019.1649132DOI Listing
October 2019

Reply to F.D. Leonard.

J Clin Oncol 2019 Oct 19;37(29):2701-2702. Epub 2019 Aug 19.

Mark Bustoros, MD; Romanos Sklavenitis-Pistofidis, MD; Jorge J. Castillo, MD; Steven P. Treon, MD, PhD; and Irene M. Ghobrial, MD, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.01708DOI Listing
October 2019

Long survival in patients with Waldenström macroglobulinaemia diagnosed at a young age.

Br J Haematol 2019 May 8;185(4):799-802. Epub 2018 Nov 8.

Bing Center for Waldenstrom Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15634DOI Listing
May 2019

Low risk of Pneumocystis jirovecii pneumonia and invasive aspergillosis in patients with Waldenström macroglobulinaemia on ibrutinib.

Br J Haematol 2019 May 20;185(4):788-790. Epub 2018 Nov 20.

Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15627DOI Listing
May 2019

Low levels of von Willebrand markers associate with high serum IgM levels and improve with response to therapy, in patients with Waldenström macroglobulinaemia.

Br J Haematol 2019 Mar 13;184(6):1011-1014. Epub 2018 Mar 13.

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15200DOI Listing
March 2019

Genomic Landscape of Waldenström Macroglobulinemia.

Hematol Oncol Clin North Am 2018 10 25;32(5):745-752. Epub 2018 Jul 25.

Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S08898588183072
Publisher Site
http://dx.doi.org/10.1016/j.hoc.2018.05.003DOI Listing
October 2018

Initial Evaluation of the Patient with Waldenström Macroglobulinemia.

Hematol Oncol Clin North Am 2018 10 23;32(5):811-820. Epub 2018 Jul 23.

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Mayer 221, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2018.05.008DOI Listing
October 2018

Waldenström Macroglobulinemia: Lessons Learned from Basic and Clinical Research.

Hematol Oncol Clin North Am 2018 10;32(5):xiii-xiv

Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, M548, Boston, MA 02215, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S08898588183075
Publisher Site
http://dx.doi.org/10.1016/j.hoc.2018.07.001DOI Listing
October 2018

Ibrutinib Monotherapy in Symptomatic, Treatment-Naïve Patients With Waldenström Macroglobulinemia.

J Clin Oncol 2018 09 25;36(27):2755-2761. Epub 2018 Jul 25.

Steven P. Treon, Joshua Gustine, Kirsten Meid, Guang Yang, Lian Xu, Xia Liu, Maria Demos, Amanda Kofides, Nicholas Tsakmaklis, Jiaji G. Chen, Manit Munshi, Gloria Chan, Toni Dubeau, Zachary R. Hunter, and Jorge J. Castillo, Dana-Farber Cancer Institute; Steven P. Treon, Guang Yang, Xia Liu, Noopur Raje, Andrew Yee, Elizabeth O'Donnell, Zachary R. Hunter, and Jorge J. Castillo, Harvard Medical School; and Noopur Raje, Andrew Yee, and Elizabeth O'Donnell, Massachusetts General Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.78.6426DOI Listing
September 2018

Ibrutinib discontinuation in Waldenström macroglobulinemia: Etiologies, outcomes, and IgM rebound.

Am J Hematol 2018 08 25;93(4):511-517. Epub 2018 Jan 25.

Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25023DOI Listing
August 2018

Ibrutinib withdrawal symptoms in patients with Waldenström macroglobulinemia.

Haematologica 2018 07 22;103(7):e307-e310. Epub 2018 Feb 22.

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2017.186908DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029546PMC
July 2018

Prospective Clinical Trial of Ixazomib, Dexamethasone, and Rituximab as Primary Therapy in Waldenström Macroglobulinemia.

Clin Cancer Res 2018 07 16;24(14):3247-3252. Epub 2018 Apr 16.

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-0152DOI Listing
July 2018

The real world of Waldenström's macroglobulinaemia.

Lancet Haematol 2018 07;5(7):e275-e276

Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(18)30091-7DOI Listing
July 2018

Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström's Macroglobulinemia.

N Engl J Med 2018 Jun 1;378(25):2399-2410. Epub 2018 Jun 1.

From the National and Kapodistrian University of Athens School of Medicine, Athens (M.A.D., E.K.); ASST Grande Ospedale Metropolitano Niguarda, Milan (A.T.), and Città della Salute Hospital and University, Turin (L.O.) - both in Italy; Concord Hospital, University of Sydney, Concord, NSW (J.T.), and Peter MacCallum Cancer Centre and St. Vincent's Hospital, Melbourne, VIC (C.T.) - both in Australia; Hospital Universitario de Salamanca, Salamanca, Spain (R.G.-S.); Ottawa Hospital, University of Ottawa, Ottawa (D.M.), and Royal Victoria Hospital at McGill University Health Centre, Montreal (C.S.) - both in Canada; Département d'Hématologie, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Université Pierre et Marie Curie, Paris (V.L.), Centre Hospitalier Universitaire de Nantes, Nantes (B.M.), and Centre Hospitalier Régional Universitaire de Lille, Institute of Hematolog-Tranfusion, Lille (C.H.) - all in France; Memorial Sloan Kettering Cancer Center, New York (M.L.P.); Colorado Blood Cancer Institute, Denver (J.V.M.); Dana-Farber Cancer Institute, Boston (S.P.T.); Pharmacyclics, Sunnyvale, CA (J.L., Z.S., T.G.); and Comprehensive Cancer Center Ulm, Institute of Experimental Cancer Research, Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany (C.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1802917DOI Listing
June 2018

Fitting mSMART Into the Current Clinical Management of Waldenström Macroglobulinemia.

JAMA Oncol 2018 05;4(5):744-745

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2017.0734DOI Listing
May 2018

Spotting the elusive Siberian tiger: Complete response to ibrutinib in a patient with Waldenström Macroglobulinemia.

Am J Hematol 2018 May 14. Epub 2018 May 14.

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25142DOI Listing
May 2018

Extracellular vesicle-mediated transfer of constitutively active MyD88 engages MyD88 and activates signaling.

Blood 2018 04 22;131(15):1720-1729. Epub 2018 Jan 22.

Department of Synthetic Biology and Immunology, National Institute of Chemistry, Ljubljana, Slovenia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-09-805499DOI Listing
April 2018

Response and survival for primary therapy combination regimens and maintenance rituximab in Waldenström macroglobulinaemia.

Br J Haematol 2018 04 22;181(1):77-85. Epub 2018 Feb 22.

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15148DOI Listing
April 2018

Comparing apples to oranges: A commentary on the Mayo study of MYD88 significance in Waldenstrom's macroglobulinemia.

Am J Hematol 2018 03 23;93(3):E69-E71. Epub 2017 Dec 23.

Department of Medicine, Harvard Medical School; and Bing Center for Waldenstrom's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24997DOI Listing
March 2018

MYD88 mutations can be used to identify malignant pleural effusions in Waldenström macroglobulinaemia.

Br J Haematol 2018 02 17;180(4):578-581. Epub 2016 Oct 17.

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14386DOI Listing
February 2018

A Chemoproteomic Approach to Query the Degradable Kinome Using a Multi-kinase Degrader.

Cell Chem Biol 2018 01 9;25(1):88-99.e6. Epub 2017 Nov 9.

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S24519456173038
Publisher Site
http://dx.doi.org/10.1016/j.chembiol.2017.10.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6427047PMC
January 2018

Toward personalized treatment in Waldenström macroglobulinemia.

Hematology Am Soc Hematol Educ Program 2017 12;2017(1):365-370

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2017.1.365DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142554PMC
December 2017

What should be the goal of therapy for Waldenström macroglobulinemia patients? Complete response should be the goal of therapy.

Blood Adv 2017 Nov 28;1(25):2486-2490. Epub 2017 Nov 28.

Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA; and Department of Medicine, Harvard Medical School, Boston MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2017005637DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729614PMC
November 2017

Ibrutinib penetrates the blood brain barrier and shows efficacy in the therapy of Bing Neel syndrome.

Br J Haematol 2017 10 13;179(2):339-341. Epub 2016 Jul 13.

Division of Hematology, Northwell Health Cancer Institute, Hofstra Northwell School of Medicine, Lake Success, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14218DOI Listing
October 2017

Comparative outcomes of immunochemotherapy regimens in Waldenström macroglobulinaemia.

Br J Haematol 2017 10 5;179(1):106-115. Epub 2017 Jul 5.

Bing Center for Waldenström Macroglobulinemia, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14828DOI Listing
October 2017

Novel approaches to targeting MYD88 in Waldenström macroglobulinemia.

Expert Rev Hematol 2017 08 28;10(8):739-744. Epub 2017 Jun 28.

a Bing Center for Waldenström Macroglobulinemia , Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2017.1343661DOI Listing
August 2017

Targeting Myddosome Assembly in Waldenstrom Macroglobulinaemia.

Br J Haematol 2017 06 13;177(5):808-813. Epub 2016 Apr 13.

Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14103DOI Listing
June 2017

Serum IgM level as predictor of symptomatic hyperviscosity in patients with Waldenström macroglobulinaemia.

Br J Haematol 2017 06 9;177(5):717-725. Epub 2017 May 9.

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14743DOI Listing
June 2017

Prospective, Multicenter Clinical Trial of Everolimus as Primary Therapy in Waldenstrom Macroglobulinemia (WMCTG 09-214).

Clin Cancer Res 2017 May 11;23(10):2400-2404. Epub 2016 Nov 11.

Bing Center for Waldenstrom's Macroglobulinemia at the Dana-Farber Cancer Institute; and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-1918DOI Listing
May 2017

Idelalisib in Waldenström macroglobulinemia: high incidence of hepatotoxicity.

Leuk Lymphoma 2017 04 26;58(4):1002-1004. Epub 2016 Aug 26.

a Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2016.1222380DOI Listing
April 2017

To select or not to select? The role of B-cell selection in determining the MYD88 mutation status in Waldenström Macroglobulinaemia.

Br J Haematol 2017 03 2;176(5):822-824. Epub 2016 Mar 2.

Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13996DOI Listing
March 2017

Genomics, Signaling, and Treatment of Waldenström Macroglobulinemia.

J Clin Oncol 2017 Mar 13;35(9):994-1001. Epub 2017 Feb 13.

All authors: Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute; and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.0814DOI Listing
March 2017

Inhibition of the Bruton Tyrosine Kinase Pathway in B-Cell Lymphoproliferative Disorders.

Cancer J 2016 Jan-Feb;22(1):34-9

From the Bing Center for Waldenström's Macroglobulinemia and Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/journalppo/2016/01000/Inhibitio
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/PPO.0000000000000170DOI Listing
November 2016

Response to ibrutinib in a patient with IgG lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation.

Leuk Lymphoma 2016 11 16;57(11):2699-701. Epub 2016 Mar 16.

a Division of Hematologic Malignancies , Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2016.1157875DOI Listing
November 2016

Renal disease related to Waldenström macroglobulinaemia: incidence, pathology and clinical outcomes.

Br J Haematol 2016 Nov 29;175(4):623-630. Epub 2016 Jul 29.

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14279DOI Listing
November 2016

Evolution of Management and Outcomes in Waldenström Macroglobulinemia: A Population-Based Analysis.

Oncologist 2016 Nov 29;21(11):1377-1386. Epub 2016 Jul 29.

Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2016-0126DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5189618PMC
November 2016

Histological transformation to diffuse large B-cell lymphoma in patients with Waldenström macroglobulinemia.

Am J Hematol 2016 10 27;91(10):1032-5. Epub 2016 Jul 27.

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusettts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24477DOI Listing
October 2016

Rituximab intolerance in patients with Waldenström macroglobulinaemia.

Br J Haematol 2016 08 2;174(4):645-8. Epub 2015 Nov 2.

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13794DOI Listing
August 2016

Ibrutinib in Waldenström macroglobulinemia: latest evidence and clinical experience.

Ther Adv Hematol 2016 Aug 13;7(4):179-86. Epub 2016 Jun 13.

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620716654102DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959643PMC
August 2016

Atrial fibrillation associated with ibrutinib in Waldenström macroglobulinemia.

Am J Hematol 2016 06 28;91(6):E312-3. Epub 2016 Apr 28.

Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24366DOI Listing
June 2016

HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinib.

Blood 2016 06 3;127(25):3237-52. Epub 2016 May 3.

Department of Medical Oncology, Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-01-695098DOI Listing
June 2016

Epigenomics in Waldenstrom's macroglobulinaemia.

Best Pract Res Clin Haematol 2016 06 25;29(2):156-160. Epub 2016 Sep 25.

ASST Spedali Civili, Department of Medical Oncology, CREA Laboratory, Brescia, Italy; Dana-Farber Cancer Institute, Department of Medical Oncology, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2016.08.022DOI Listing
June 2016

Future therapeutic options for patients with Waldenström macroglobulinemia.

Best Pract Res Clin Haematol 2016 06 14;29(2):206-215. Epub 2016 Sep 14.

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2016.08.021DOI Listing
June 2016

Toward Personalized Lymphoma Immunotherapy: Identification of Common Driver Mutations Recognized by Patient CD8+ T Cells.

Clin Cancer Res 2016 05 2;22(9):2226-36. Epub 2015 Dec 2.

Trev and Joyce Deeley Research Centre, British Columbia Cancer Agency, Victoria, British Columbia, Canada. Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada. Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-2023DOI Listing
May 2016

Ibrutinib and idelalisib target B cell receptor- but not CXCL12/CXCR4-controlled integrin-mediated adhesion in Waldenström macroglobulinemia.

Haematologica 2016 Mar 3;101(3):e111-5. Epub 2015 Dec 3.

Department of Pathology, Academic Medical Center, University of Amsterdam, The Netherlands Lymphoma and Myeloma Center Amsterdam - LYMMCARE, The Netherlands

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2015.137265DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815740PMC
March 2016

Survival outcomes of secondary cancers in patients with Waldenström macroglobulinemia: An analysis of the SEER database.

Am J Hematol 2015 Aug 28;90(8):696-701. Epub 2015 May 28.

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24052DOI Listing
August 2015

How I treat Waldenström macroglobulinemia.

Authors:
Steven P Treon

Blood 2015 Aug 22;126(6):721-32. Epub 2015 May 22.

Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-01-553974DOI Listing
August 2015

MYD88 Mutations and Response to Ibrutinib in Waldenström's Macroglobulinemia.

N Engl J Med 2015 Aug;373(6):584-6

Bing Center for Waldenström's Macroglobulinemia, Boston MA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1506192DOI Listing
August 2015

Incidence of secondary malignancies among patients with Waldenström macroglobulinemia: An analysis of the SEER database.

Cancer 2015 Jul 10;121(13):2230-6. Epub 2015 Mar 10.

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29334DOI Listing
July 2015

Cyclophosphamide, bortezomib, and dexamethasone combination in waldenstrom macroglobulinemia.

Am J Hematol 2015 Jun 10;90(6):E122-3. Epub 2015 May 10.

Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23985DOI Listing
June 2015

Targeting the Spleen Tyrosine Kinase with Fostamatinib as a Strategy against Waldenström Macroglobulinemia.

Clin Cancer Res 2015 Jun 6;21(11):2538-45. Epub 2015 Mar 6.

Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-1462DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737551PMC
June 2015

Overall survival and competing risks of death in patients with Waldenström macroglobulinaemia: an analysis of the Surveillance, Epidemiology and End Results database.

Br J Haematol 2015 Apr 18;169(1):81-9. Epub 2014 Dec 18.

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13264DOI Listing
April 2015

Biology, prognosis, and therapy of Waldenström Macroglobulinemia.

Cancer Treat Res 2015 ;165:177-95

Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, M221, 02215, Boston, MA, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-319-13150-4_7DOI Listing
April 2015

Ibrutinib in previously treated Waldenström's macroglobulinemia.

N Engl J Med 2015 Apr;372(15):1430-40

From the Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute (S.P.T., C.K.T., K.M., D.W., G.Y., Y.C., L.X., C.J.P., S.K., I.G., J.J.C., J.P.L., Z.R.H.), Harvard Medical School (S.P.T., G.Y., Y.C., S.R., J.C.A., N.L.H., I.G., J.J.C., J.P.L.), Department of Pathology, Brigham and Women's Hospital (S.R., J.C.A.), Department of Pathology, Massachusetts General Hospital (N.L.H.), and Department of Pathology, Boston University Medical Center (Z.R.H.) - all in Boston; Memorial Sloan Kettering Cancer Center, New York (R.G., K.V.A., M.L.P.); and Stanford University Medical Center, Stanford (G.V., J.L.Z., R.H.A.), and Pharmacyclics, Sunnyvale (Z.S., J.L., M.C., F.C., T.G.) - both in California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1501548DOI Listing
April 2015

CXCR4 WHIM-like frameshift and nonsense mutations promote ibrutinib resistance but do not supplant MYD88(L265P) -directed survival signalling in Waldenström macroglobulinaemia cells.

Br J Haematol 2015 Mar 5;168(5):701-7. Epub 2014 Nov 5.

Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13200DOI Listing
March 2015

Waldenström macroglobulinemia.

Hematol Oncol Clin North Am 2014 Oct 5;28(5):945-70. Epub 2014 Aug 5.

Department of Molecular Medicine, Amyloidosis Research and Treatment Center, University Hospital Policlinico San Matteo, Viale C. Golgi, 19, Pavia 27100, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2014.06.003DOI Listing
October 2014

Survival trends in Waldenström macroglobulinemia: an analysis of the Surveillance, Epidemiology and End Results database.

Blood 2014 Jun;123(25):3999-4000

Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-05-574871DOI Listing
June 2014